$BRVO
Bravo Multinational Inc.

2023 Q4 Form 10-Q Financial Statement

#000109181823000186 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $102.0K $110.0K
YoY Change -19.43% -13.47%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $102.0K $107.7K
YoY Change -19.43% -15.26%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$102.1K $4.528M
YoY Change -19.36% -3661.44%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$102.1K $4.528M
YoY Change -19.35% -3661.43%
Net Earnings / Revenue
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share $0.00 -$0.09
COMMON SHARES
Basic Shares Outstanding 56.14M shares 47.64M shares
Diluted Shares Outstanding 47.95M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.180K $10.00K
YoY Change 1585.71% 9900.0%
Cash & Equivalents $1.180K $2.535K
Short-Term Investments
Other Short-Term Assets $30.00K
YoY Change
Inventory
Prepaid Expenses $29.33K
Receivables $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.180K $31.86K
YoY Change 1516.44% 30832.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.180K $31.86K
Total Long-Term Assets $0.00 $0.00
Total Assets $1.180K $31.86K
YoY Change 1516.44% 30832.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.45K $20.00K
YoY Change 1560.0% 5614.29%
Accrued Expenses $207.3K $160.0K
YoY Change -86.52% -88.72%
Deferred Revenue $35.80K
YoY Change
Short-Term Debt $154.3K $120.0K
YoY Change -20.3% -35.53%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $409.9K $350.0K
YoY Change -76.81% -78.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $409.9K $350.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $409.9K $230.7K
YoY Change -76.81% -85.94%
SHAREHOLDERS EQUITY
Retained Earnings -$95.79M -$91.16M
YoY Change 5.33% 0.38%
Common Stock $4.763K $4.763K
YoY Change 0.0% -99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$408.7K -$198.9K
YoY Change
Total Liabilities & Shareholders Equity $1.180K $31.86K
YoY Change 1516.44% 30832.04%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$102.1K $4.528M
YoY Change -19.35% -3661.43%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$45.34K -$40.00K
YoY Change 506.96% 373.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.45K 50.00K
YoY Change 389.26% 488.24%
NET CHANGE
Cash From Operating Activities -45.34K -40.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 36.45K 50.00K
Net Change In Cash -8.890K 10.00K
YoY Change 44350.0% 16566.67%
FREE CASH FLOW
Cash From Operating Activities -$45.34K -$40.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001444839
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2023Q3 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2022Q3 brvo Goodwill Impairment
GoodwillImpairment
usd
brvo Goodwill Impairment
GoodwillImpairment
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
usd
brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q3 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2022Q4 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-53505
dei Entity Registrant Name
EntityRegistrantName
BRAVO MULTINATIONAL INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4068651
dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
dei City Area Code
CityAreaCode
757
dei Local Phone Number
LocalPhoneNumber
306-6090
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
BRVO
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56141011 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9415 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
29325 usd
CY2023Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2023Q3 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
38740 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
73 usd
CY2023Q3 us-gaap Assets
Assets
38740 usd
CY2022Q4 us-gaap Assets
Assets
73 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
24373 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
750 usd
CY2023Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2023Q3 brvo Due To Related Parties
DueToRelatedParties
121555 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
163500 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1537417 usd
CY2023Q3 us-gaap Liabilities
Liabilities
345228 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1767537 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56141010 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56141010 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5613 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95375503 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89168493 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95687586 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90940720 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-306470 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1767464 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
-18 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-306488 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1767464 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38740 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10594 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2207 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16016 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7087 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
53388 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
6175 usd
us-gaap Professional Fees
ProfessionalFees
102764 usd
us-gaap Professional Fees
ProfessionalFees
38090 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
43750 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
118750 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
206250 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
356250 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
107732 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
127132 usd
us-gaap Operating Expenses
OperatingExpenses
325030 usd
us-gaap Operating Expenses
OperatingExpenses
401427 usd
CY2023Q3 brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-107732 usd
CY2022Q3 brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-127132 usd
brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-325030 usd
brvo Loss From Operations Before Goodwill Impairment
LossFromOperationsBeforeGoodwillImpairment
-401427 usd
CY2023Q3 brvo Goodwill Impairment
GoodwillImpairment
4420000 usd
brvo Goodwill Impairment
GoodwillImpairment
4420000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4527732 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
127132 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4745030 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
401427 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
4527732 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
127132 usd
us-gaap Profit Loss
ProfitLoss
4745030 usd
us-gaap Profit Loss
ProfitLoss
401427 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4527714 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
127132 usd
us-gaap Net Income Loss
NetIncomeLoss
4745012 usd
us-gaap Net Income Loss
NetIncomeLoss
401427 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47952366 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47952366 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47952366 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47952366 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Profit Loss
ProfitLoss
4745030 usd
us-gaap Profit Loss
ProfitLoss
401427 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
29325 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-40 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23623 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-417 usd
brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
206250 usd
brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
356249 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-124482 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45555 usd
us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
100 usd
us-gaap Proceeds From Partnership Contribution
ProceedsFromPartnershipContribution
100 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
133724 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
45464 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133824 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45564 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9342 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9415 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102 usd
brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
1580167 usd
brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
205739 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1239506 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-147241 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1386747 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-127054 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1513801 usd
CY2022Q3 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
100 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-127132 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1640833 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1767464 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-143462 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1910926 usd
CY2023Q2 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1785906 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73836 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-198856 usd
CY2023Q3 brvo Merger With Rpi And Share Issuance
MergerWithRpiAndShareIssuance
4420000 usd
CY2023Q3 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
100 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4527732 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-306488 usd
brvo Net Royalty Percentage
NetRoyaltyPercentage
0.15 pure
CY2023Q3 us-gaap Area Of Land
AreaOfLand
76.63 acre
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zw72j4O7mkUg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z10cVBwZd6M1">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
42312 usd
CY2023Q3 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2022Q4 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2023Q3 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q3 brvo Due To Related Parties
DueToRelatedParties
121555 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q3 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
850 usd
brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2022Q3 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
1720 usd
brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2023Q3 brvo Filing Fees
FilingFees
1165 usd
CY2022Q3 brvo Filing Fees
FilingFees
0 usd
brvo Filing Fees
FilingFees
2095 usd
brvo Filing Fees
FilingFees
0 usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 brvo Shares Authorized
SharesAuthorized
1050000000 shares
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
4516667 shares
CY2023Q3 brvo Rent Expense
RentExpense
0 usd
brvo Rent Expense
RentExpense
0 usd
CY2022Q3 brvo Rent Expense
RentExpense
0 usd
brvo Rent Expense
RentExpense
0 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
8500000 shares
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4420000 usd

Files In Submission

Name View Source Status
brvo-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001091818-23-000186-index-headers.html Edgar Link pending
0001091818-23-000186-index.html Edgar Link pending
0001091818-23-000186.txt Edgar Link pending
0001091818-23-000186-xbrl.zip Edgar Link pending
brvo-20230930.xsd Edgar Link pending
brvo20230930.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
brvo-20230930_def.xml Edgar Link unprocessable
brvo-20230930_lab.xml Edgar Link unprocessable
brvo-20230930_pre.xml Edgar Link unprocessable
brvo20230930_htm.xml Edgar Link completed
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending